BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36465975)

  • 1. 2020 Chinese Expert-based Consensus on the Diagnosis and Treatment of Connective Tissue Disease Associated Pulmonary Arterial Hypertension.
    Zhao J; Wang Q; Wang Q; Zhang Y; Zhang N; Zhang R; Hao Y; Jia J; Li M; Zeng X; ; ; ;
    Rheumatol Immunol Res; 2021 Jun; 2(2):63-78. PubMed ID: 36465975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [2020 Chinese expert-based consensus statement regarding the diagnosis and treatment of connective tissue disease associated pulmonary arterial hypertension].
    ; ;
    Zhonghua Nei Ke Za Zhi; 2021 May; 60(5):406-420. PubMed ID: 33906271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [2018 Chinese expert-based consensus statement regarding the diagnosis and treatment of interstitial lung disease associated with connective tissue diseases].
    ;
    Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):558-565. PubMed ID: 30060326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of interstitial lung disease in rheumatic diseases: A joint statement from the Portuguese Pulmonology Society, the Portuguese Rheumatology Society, and the Portuguese Radiology and Nuclear Medicine Society.
    Morais A; Duarte AC; Fernandes MO; Borba A; Ruano C; Marques ID; Calha J; Branco JC; Pereira JM; Salvador MJ; Bernardes M; Khmelinskii N; Pinto P; Pinto-Basto R; Freitas S; Campainha S; Alfaro T; Cordeiro A
    Pulmonology; 2023 Dec; ():. PubMed ID: 38148269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2023 Taiwan Society of Cardiology (TSOC) and Taiwan College of Rheumatology (TCR) Joint Consensus on Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    Huang WC; Hsieh SC; Wu YW; Hsieh TY; Wu YJ; Li KJ; Charng MJ; Chen WS; Sung SH; Tsao YP; Ho WJ; Lai CC; Cheng CC; Tsai HC; Hsu CH; Lu CH; Chiu YW; Shen CY; Wu CH; Liu FC; Lin YH; Yeh FC; Liu WS; Lee HT; Wu SH; Chang CC; Chu CY; Hou CJ; Tsai CY
    Acta Cardiol Sin; 2023 Mar; 39(2):213-241. PubMed ID: 36911549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early risk prediction in idiopathic
    Hjalmarsson C; Kjellström B; Jansson K; Nisell M; Kylhammar D; Kavianipour M; Rådegran G; Söderberg S; Wikström G; Wuttge DM; Hesselstrand R
    ERJ Open Res; 2021 Jul; 7(3):. PubMed ID: 34350280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future.
    Zhao J; Wang Q; Deng X; Qian J; Tian Z; Liu Y; Li M; Zeng X
    Pharmacol Ther; 2022 Nov; 239():108192. PubMed ID: 35461923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recommendations for the diagnosis and treatment of connective tissue disease associated pulmonary arterial hypertension in China].
    Zhang X; Zhao JL; Ding F; Yang J; Wang J; Zeng XF; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2022 Nov; 61(11):1206-1216. PubMed ID: 36323561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2009 ESC/ERS pulmonary hypertension guidelines and connective tissue disease.
    Nakanishi N; ;
    Allergol Int; 2011 Dec; 60(4):419-24. PubMed ID: 22015568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pulmonary arterial pressure in patients with connective tissue disease-associated pulmonary arterial hypertension by myocardial perfusion imaging.
    Wang Z; Li J; Wang X; Liu M; Liao M; Zhang C; Shang X
    Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12927. PubMed ID: 34908208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive therapy in patients with connective tissue disease-associated pulmonary arterial hypertension: A systematic review.
    Ding Y; Qian J; Zhang S; Xu D; Leng X; Zhao J; Wang Q; Zhang W; Tian X; Li M; Zeng X
    Int J Rheum Dis; 2022 Sep; 25(9):982-990. PubMed ID: 35699128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: a single-center retrospective study.
    Wang J; Wang Y; Li X; Huang Y; Sun X; Wang Q; Zhang M
    BMC Pulm Med; 2020 Oct; 20(1):272. PubMed ID: 33076877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension in connective tissue diseases: an update.
    Aithala R; Alex AG; Danda D
    Int J Rheum Dis; 2017 Jan; 20(1):5-24. PubMed ID: 28205373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recommendations for the diagnosis and treatment of connective tissue disease-associated interstitial lung disease in China].
    Zou QH; Lu YW; Zhou JG; Liu XX; Li MT; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2022 Nov; 61(11):1217-1223. PubMed ID: 36323562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
    Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
    BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis.
    Lewis C; Sanderson R; Vasilottos N; Zheutlin A; Visovatti S
    Heart Fail Clin; 2023 Jan; 19(1):45-54. PubMed ID: 36435572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.
    Shahane A
    Rheumatol Int; 2013 Jul; 33(7):1655-67. PubMed ID: 23334373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of pulmonary arterial hypertension secondary to connective tissue disease in children].
    Xing Y; Song HM; Wu XY; He YY; Wei M
    Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):822-6. PubMed ID: 19099898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.
    Saketkoo LA; Mittoo S; Huscher D; Khanna D; Dellaripa PF; Distler O; Flaherty KR; Frankel S; Oddis CV; Denton CP; Fischer A; Kowal-Bielecka OM; LeSage D; Merkel PA; Phillips K; Pittrow D; Swigris J; Antoniou K; Baughman RP; Castelino FV; Christmann RB; Christopher-Stine L; Collard HR; Cottin V; Danoff S; Highland KB; Hummers L; Shah AA; Kim DS; Lynch DA; Miller FW; Proudman SM; Richeldi L; Ryu JH; Sandorfi N; Sarver C; Wells AU; Strand V; Matteson EL; Brown KK; Seibold JR;
    Thorax; 2014 May; 69(5):428-36. PubMed ID: 24368713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of interstitial lung disease associated with connective tissue disease.
    Mathai SC; Danoff SK
    BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.